Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBI-087 in seropositive rheumatoid arthritis on background methotrexate
2009-010516-15Phase 2Completed
- Sponsor
- Wyeth
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sbi-087 in rheumatoid arthritis (RA) (5 arms), sponsored by Wyeth. Primary endpoint: ACR20 response at week 16 (mITT). Started Jul 2009; status: completed.
02
Drugs
sbi-087
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-010516-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010516-15.